This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McDermott, D. H. Articles by Benjamin, E. J. Search for Related Content PubMed PubMed Citation Articles by McDermott, D. H. Articles by Benjamin, E. J. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Medline Plus Health Information Heart Attack Related Collections Epidemiology Genetics of cardiovascular disease Pathophysiology Risk Factors Related Article

(Circulation. 2005;112:1113-1120.)
© 2005 American Heart Association, Inc.

Epidemiology

CCL2 Polymorphisms Are Associated With Serum Monocyte Chemoattractant Protein-1 Levels and Myocardial Infarction in the Framingham Heart Study

David H. McDermott, MD; Qiong Yang, PhD; Sekar Kathiresan, MD; L. Adrienne Cupples, PhD; Joseph M. Massaro, PhD; John F. Keaney, Jr, MD; Martin G. Larson, ScD; Ramachandran S. Vasan, MD; Joel N. Hirschhorn, MD, PhD; Christopher J. O’Donnell, MD, MPH; Philip M. Murphy, MD; Emelia J. Benjamin, MD, ScM

From the Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md (D.H.M., P.M.M.); Department of Biostatistics, School of Public Health (Q.Y., L.A.C.), Department of Mathematics (J.M.M., M.G.L.), and School of Medicine (J.F.K., R.S.V., E.J.B.), Boston University, Boston, Mass; Cardiology Division, Massachusetts General Hospital (S.K., C.J.O.) and Department of Genetics (J.N.H.), Harvard Medical School, Boston, Mass; Broad Institute, Cambridge, Mass (S.K., C.J.O.); National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Md (C.J.O.); and National Heart, Lung and Blood Institute’s Framingham Heart Study, Framingham, Mass (S.K., R.S.V., C.J.O., E.J.B.).

Correspondence to David H. McDermott, MD, NIAID, NIH Bldg 10, Room 11N111, Bethesda, MD 20892-1886 (e-mail dmcdermott{at}niaid.nih.gov); or Emelia J. Benjamin, MD, ScM, Framingham Heart Study, 73 Mt Wayte Ave, Suite 2, Framingham, MA 01702-5827 (e-mail emelia@bu.edu).

Received February 8, 2005; revision received April 21, 2005; accepted May 5, 2005.

Background— Monocyte chemoattractant protein-1 (MCP-1) is a chemokine strongly implicated in promoting atherosclerosis in animal models, but human genetic evidence is contradictory.

Methods and Results— We analyzed the association of genetic variation in the MCP-1 gene (CCL2) with prevalent myocardial infarction and serum MCP-1 levels in the community-based Framingham Heart Study Offspring Cohort (50% women; mean age, 62 years). MCP-1 levels and CCL2 genotypes were determined in 3236 and 1797 individuals, respectively. Significant clinical correlates of MCP-1 levels were age, cigarette smoking, triglycerides, body mass index, and waist-to-hip ratio. The MCP-1-2578G allele located in the CCL2 regulatory region was significantly associated with both higher serum MCP-1 levels in a recessive genetic model (358±10 versus 328±3 pg/mL; P=0.002) and higher prevalence of myocardial infarction in a dominant genetic model (adjusted odds ratio, 2.0; 95% CI, 1.2 to 3.3; P=0.005). We also defined the linkage disequilibrium structure at the CCL2 locus and observed 6 common haplotypes in whites. We performed haplotype-based association analysis and found that only the most frequent haplotype, defined by the MCP-1-2578G allele, was associated with prevalent MI.

Conclusions— Our data are consistent with the hypothesis that MCP-1 is involved in the pathogenesis of human atherosclerosis and myocardial infarction.

Key Words: epidemiology • genetics • inflammation • myocardial infarction • risk factors

Related Article:

Issue Highlights
Circulation 2005 112: 1081. [Full Text]

This article has been cited by other articles:

				A. R. Afzal, S. Kiechl, Y. P. Daryani, A. Weerasinghe, Y. Zhang, M. Reindl, A. Mayr, S. Weger, Q. Xu, and J. Willeit Common CCR5-del32 Frameshift Mutation Associated With Serum Levels of Inflammatory Markers and Cardiovascular Disease Risk in the Bruneck Population Stroke, July 1, 2008; 39(7): 1972 - 1978. [Abstract] [Full Text] [PDF]

				N. Saederup, L. Chan, S. A. Lira, and I. F. Charo Fractalkine Deficiency Markedly Reduces Macrophage Accumulation and Atherosclerotic Lesion Formation in CCR2-/- Mice: Evidence for Independent Chemokine Functions in Atherogenesis Circulation, April 1, 2008; 117(13): 1642 - 1648. [Abstract] [Full Text] [PDF]

				J. A. de Lemos, D. A. Morrow, M. A. Blazing, P. Jarolim, S. D. Wiviott, M. S. Sabatine, R. M. Califf, and E. Braunwald Serial Measurement of Monocyte Chemoattractant Protein-1 After Acute Coronary Syndromes: Results From the A to Z Trial J. Am. Coll. Cardiol., November 27, 2007; 50(22): 2117 - 2124. [Abstract] [Full Text] [PDF]

				N. G. Frangogiannis The Prognostic Value of Monocyte Chemoattractant Protein-1/CCL2 in Acute Coronary Syndromes J. Am. Coll. Cardiol., November 27, 2007; 50(22): 2125 - 2127. [Full Text] [PDF]

				A.O. Kraaijeveld, S.C.A. de Jager, W.J. de Jager, B.J. Prakken, S.R. McColl, I. Haspels, H. Putter, T.J.C. van Berkel, L. Nagelkerken, J.W. Jukema, et al. CC Chemokine Ligand-5 (CCL5/RANTES) and CC Chemokine Ligand-18 (CCL18/PARC) Are Specific Markers of Refractory Unstable Angina Pectoris and Are Transiently Raised During Severe Ischemic Symptoms Circulation, October 23, 2007; 116(17): 1931 - 1941. [Abstract] [Full Text] [PDF]

				J. Barlic and P. M. Murphy Chemokine regulation of atherosclerosis J. Leukoc. Biol., August 1, 2007; 82(2): 226 - 236. [Abstract] [Full Text] [PDF]

				A. L. Jefferson, J. M. Massaro, P. A. Wolf, S. Seshadri, R. Au, R. S. Vasan, M. G. Larson, J. B. Meigs, J. F. Keaney Jr, I. Lipinska, et al. Inflammatory biomarkers are associated with total brain volume: The Framingham Heart Study Neurology, March 27, 2007; 68(13): 1032 - 1038. [Abstract] [Full Text] [PDF]

				C. Herder, J. Baumert, B. Thorand, S. Martin, H. Lowel, H. Kolb, and W. Koenig Chemokines and Incident Coronary Heart Disease: Results From the MONICA/KORA Augsburg Case-Cohort Study, 1984-2002 Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 2147 - 2152. [Abstract] [Full Text] [PDF]

				K. Bidzhekov, A. Zernecke, and C. Weber MCP-1 Induces a Novel Transcription Factor With Proapoptotic Activity Circ. Res., May 12, 2006; 98(9): 1107 - 1109. [Full Text] [PDF]

				A. R. Lucas, R. Korol, and C. J. Pepine Inflammation in Atherosclerosis: Some Thoughts About Acute Coronary Syndromes Circulation, May 2, 2006; 113(17): e728 - e732. [Full Text] [PDF]

				E. B. Loucks, L. M. Sullivan, L. J. Hayes, R. B. D'Agostino Sr., M. G. Larson, R. S. Vasan, E. J. Benjamin, and L. F. Berkman Association of Educational Level with Inflammatory Markers in the Framingham Offspring Study Am. J. Epidemiol., April 1, 2006; 163(7): 622 - 628. [Abstract] [Full Text] [PDF]

				S. Kathiresan, M. G. Larson, R. S. Vasan, C.-Y. Guo, P. Gona, J. F. Keaney Jr, P. W.F. Wilson, C. Newton-Cheh, S. L. Musone, A. L. Camargo, et al. Contribution of Clinical Correlates and 13 C-Reactive Protein Gene Polymorphisms to Interindividual Variability in Serum C-Reactive Protein Level Circulation, March 21, 2006; 113(11): 1415 - 1423. [Abstract] [Full Text] [PDF]